Tzu-Hsiu Chen

An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays.

Luc Girard, Matthew Meyerson, Xiaojun Zhao, 2004, Cancer research.

High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines

David C Christiani, Cheng Li, Luc Girard, 2004, Oncogene.

Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.

Laura Tolosi, Michael Peyton, Thomas Zander, 2009, The Journal of clinical investigation.

Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing

Thomas LaFramboise, Levi A Garraway, Kwok-Kin Wong, 2006, Nature Medicine.

Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation.

Martin Peifer, Daniel Rauh, Lars Ruddigkeit, 2010, Cancer research.

Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants

William C Hahn, Matthew Meyerson, William R Sellers, 2005, PLoS medicine.

Drug-sensitive FGFR2 mutations in endometrial carcinoma

Kristian Cibulskis, Wendy Winckler, Michael C Zody, 2008, Proceedings of the National Academy of Sciences.

Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2

Wendy Winckler, Gad Getz, Steven A Carr, 2012, Proceedings of the National Academy of Sciences.